ReviewJournal of fungi (Basel, Switzerland)2019
Mucormycosis in Burn Patients.
Review in Journal of fungi (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 31 citations in OpenAlex.
- Managing skin infections in burn patients: principles and pitfalls.Current opinion in infectious diseases · 2026Review
- Characteristics of mycological criteria for the diagnosis of invasive mold infections in patients with severe burn injury.Journal of clinical microbiology · 2026Article
- Postburn Auricular Mucormycosis in an Immunocompetent Patient: Early Diagnosis and Multidisciplinary Management.Cureus · 2025Article
- Management and Surgical Dressing Protocol for Cutaneous Mucormycosis After a Blast Injury: A Case Report.The American journal of case reports · 2025Article
- Angioinvasive mucormycosis in burn intensive care units: A case report and review of literature.World journal of critical care medicine · 2024Article
- [Research progress of mucormycosis in burns].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2023Review
- Article
- [Analysis of clinical characteristics and risk factors of death in critical burn patients complicated with invasive fungal infection].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2023Article
- Epidemiology, Modern Diagnostics, and the Management of Mucorales Infections.Journal of fungi (Basel, Switzerland) · 2023Review
- [Research advances on invasive fungal infections after burns].Zhonghua shao shang yu chuang mian xiu fu za zhi · 2023Review
- Invasive cutaneous mucormycosis: A case report on a deadly complication of a severe burn.IDCases · 2022Article
- Performance of Existing Definitions and Tests for the Diagnosis of Invasive Fungal Diseases other than Invasive Candidiasis and Invasive Aspergillosis in Critically Ill, Adult Patients: A Systematic Review with Qualitative Evidence Synthesis.Journal of fungi (Basel, Switzerland) · 2021Article
- Pilot study on burden of fungal contamination in face masks: need for better mask hygiene in the COVID-19 era.Le infezioni in medicina · 2021Article
- Outbreaks of Mucorales and the Species Involved.Mycopathologia · 2020Review
- Mould Infections of Traumatic Wounds: A Brief Narrative Review.Infectious diseases and therapy · 2020Review
- Special Issue: Mucorales and Mucormycosis.Journal of fungi (Basel, Switzerland) · 2019Article
- Necrotizing Mucormycosis of Wounds Following Combat Injuries, Natural Disasters, Burns, and Other Trauma.Journal of fungi (Basel, Switzerland) · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with extensive burns are an important group at risk for cutaneous mucormycosis. This study aimed to perform a systematic review of all reported mucormycosis cases in burn patients from 1990 onward. A Medline search yielded identification of 7 case series, 3 outbreaks, and 25 individual cases reports. The prevalence reached 0.04%⁻0.6%. The median age was 42⁻48 in the case series and outbreaks, except for the studies from military centers (23.5⁻32.5) and in individual reports (29.5). The median total body surface area reached 42.5%⁻65%. Various skin lesions were described, none being pathognomonic: the diagnosis was mainly reached because of extensive necrotic lesions sometimes associated with sepsis. Most patients were treated with systemic amphotericin B or liposomal amphotericin B, and all underwent debridement and/or amputation. Mortality reached 33%⁻100% in the case series, 29%⁻62% during outbreaks, and 40% in individual cases. Most patients were diagnosed using histopathology and/or culture. Mucorales qPCR showed detection of circulating DNA 2⁻24 days before the standard diagnosis. Species included the main clinically relevant mucorales (i.e.,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.